Bastide le Confort Medical Aktie
| 24,45EUR | -0,20EUR | -0,81% |
WKN: 907048 / ISIN: FR0000035370
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 3 039 | 3 375 | 3 546 | 3 651 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,15 | 0,14 | 0,14 | 0,15 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 164 | 187 | 196 | 209 | 277 |
| Summe Anlagevermögen | 405 | 446 | 461 | 438 | 384 |
| Summe Aktiva | 569 | 633 | 657 | 647 | 661 |
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 484 | 546 | 569 | 566 | 590 |
| Summe Eigenkapital | 85 | 87 | 88 | 81 | 71 |
| Summe Passiva | 569 | 633 | 657 | 647 | 661 |
Adresse
| Centre d'Activité Euro 2000, 30132 Caissargues | |
| Telefon | +33 (4) 66-38-68-08 |
| Internet | http://www.bastide-groupe.fr |
Management
|
Caroline Nabonne
Director |
|
Julie Caredda
Independent Director |
|
Kelly Guichard
Independent Director |
|
Olivier Jourdanney
Deputy Chief Executive Officer |
|
Olivier Mares
Independent Director |
|
Robert Fabrega
Independent Director |
|
Vincent Bastide
Chairman & Chief Executive Officer |